Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Bioconjugate Chemistry|February 7, 2020
Photocontrolled Reversible Binding between the Protein A-Derived Z Domain and Immunoglobulin GAnders Myrhammar, Daniel Rosik, Amelie Eriksson KarlströmJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2012
Tumor targeting using affibody molecules: interplay of affinity, target expression level, and binding site compositionVladimir Tolmachev, Thuy A Tran, Daniel Rosik, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 20, 2009
Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amountVladimir Tolmachev, Daniel Rosik, Helena Wållberg, et al.Bioconjugate Chemistry|May 28, 2013
Influence of nuclides and chelators on imaging using affibody molecules: comparative evaluation of recombinant affibody molecules site-specifically labeled with ⁶⁸Ga and ¹¹¹In via maleimido derivatives of DOTA and NODAGAMohamed Altai, Joanna Strand, Daniel Rosik, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumorsVladimir Tolmachev, Fredrik Y Nilsson, Charles Widström, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2011
Direct comparison of 111In-labelled two-helix and three-helix Affibody molecules for in vivo molecular imagingDaniel Rosik, Anna Orlova, Jennie Malmberg, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 9, 2009
Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imagingThuy A Tran, Daniel Rosik, Lars Abrahmsén, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2013
Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion proteinAnna Orlova, Andreas Jonsson, Daniel Rosik, et al.Nuclear Medicine and Biology|January 30, 2013
Evaluation of backbone-cyclized HER2-binding 2-helix affibody molecule for in vivo molecular imagingHadis Honarvar, Nima Jokilaakso, Karl Andersson, et al.Bioconjugate Chemistry|January 1, 2008
Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody moleculesSara Ahlgren, Anna Orlova, Daniel Rosik, et al.Pageof 2